| ●Editorial | Kurokawa T | 4 |
| ●The status and perspectives of compensation for research-related injuries | ||
| Protection of human subjects and compensation for research-related injuries Proposal of explanation sheet based on survey of the actual status in Japan | Watanabe H，Kageyama S， Kusuoka H，et al. | 5-29 |
| Right to compensation of volunteers for research-related injuries Comparative study and future perspective in view of global clinical trials | Kurihara C | 31-62 |
| ●The 29th Aso-Kujyu Conference on Clinical Pharmacology and Therapeutics Chairman：Nomoto M，Ohashi K，Higuchi S，Sasaguri T， Hasegawa J，Yamada K，Nakano S | 63-132 | |
| Opening remarks | Nomoto M | 65-6 |
| Medical device policy in the New Growth Strategy of Japan | Takayama K | 67-76 |
| Development of Medical Devices at Panasonic | Okazaki Y | 77-86 |
| Perspective for the development of medical devices from a clinician's view | Watanabe Y | 87-98 |
| The role of CRC to implement clinical trials of medical devices effectively | Yamasaki C | 99-105 |
| Discussion | 106-8 | |
| Present conditions and future prospect for academic CROs | Tateishi T | 109-16 |
| Department of Clinical Pharmacology Phase I Unit at University of Miami | Nomoto M | 117-9 |
| Korean situation of AROs (Academic Research Organization) | Ohashi K，Iijima H | 120-5 |
| Introduction of Centre for Human Drug Research in the Netherlands | Uchida E | 126-31 |
| Closing remarks | Sasaguri T | 132 |
| ●The 1st consensus meeting for stroke cell therapy Organized by：Translational Research Informatics Center, Foundation for Biomedical Research and Innovation | 133-66 | |
| Opening remarks: Clinical development of stem cell therapy | Fukushima M | 135-8 |
| Therapeutic application of MSC for brain diseases | Ochiya T | 139-41 |
| Global trends and discussion points on stroke cell therapy trials | Nagai Y | 142-8 |
| Autologous bone marrow mononuclear cell transplantation for stroke patients | Taguchi A | 149-57 |
| Intravenous administration of auto serum-expanded autologous mesenchymal stem cells derived from bone marrow into stroke patients | Honmou O | 158-64 |
| Discussion/Summary | 165-6 | |
| ●Interview | ||
| What is the regulatory science? Concept and history in United States and in Japan ─Interview with Professor Sheila Jasanoff─ ・Full text version in English is here ! | Jasanoff S （Interview and trans. by Kurihara C，Saio T） | 167-80 |
| ●In Memoriam | ||
| Toshiharu Fujita(1952-2011): An appreciation of his research in clinical evaluation | Tsubaki H | 181-5 |
| ●Forum | ||
| Message from KitARO(No. 1): Sagami-no-Hikoju | Itoh K | 187-91 |
| Knowledge to learn about drug-induced suffering: Educational toolkit for prevention of recurrence | Saio T | 192-3 |
| Large-scale disasters and ethics of medical research | Kurihara C | 194-7 |
| ●Instructions for authors [Japanese] & [English] | 199-207 | |
| ●Editor's note | Yamazaki T | 209 |